What is BioCryst Pharmaceuticals's common stock?

BioCryst Pharmaceuticals (BCRX) reported common stock of 450M in Q1 2026.

How has BioCryst Pharmaceuticals's common stock changed year-over-year?

BioCryst Pharmaceuticals's common stock decreased by 0.0% year-over-year, from 450M to 450M.

What is the long-term trend for BioCryst Pharmaceuticals's common stock?

Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's common stock has grown at a 202.8% compound annual growth rate (CAGR), from 1.8M to 450M.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

BioCryst Pharmaceuticals BCRX Common Stock

Common Stock at other companies

Ionis PharmaceuticalsIONS

300M0.0%

Ultragenyx PharmaceuticalRARE

$0-100%

BridgeBio PharmaBBIO

500M+253,707%

Arrowhead ResearchARWR

$236K+2.6%

Agios PharmaceuticalsAGIO

$76K+2.7%

ALN

Alnylam PharmaceuticalsALNY

250M0.0%

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's common stock?: BioCryst Pharmaceuticals (BCRX) reported common stock of 450M in Q1 2026.
How has BioCryst Pharmaceuticals's common stock changed year-over-year?: BioCryst Pharmaceuticals's common stock decreased by 0.0% year-over-year, from 450M to 450M.
What is the long-term trend for BioCryst Pharmaceuticals's common stock?: Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's common stock has grown at a 202.8% compound annual growth rate (CAGR), from 1.8M to 450M.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).